Corium to Present at Jerferies 2015 Global Healthcare Conference
MENLO PARK, Calif. , May 20, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple, Corium’s President and…
Corium Announces Publication of Promising Data for Needle-Free Transdermal Influenza Vaccine
Results Published in Scientific Journal Vaccine Demonstrate Corium’s MicroCor(R) System Effectively Delivers Influenza Vaccine…
Corium Reports Second Quarter Fiscal 2015 Finacial Results
MENLO PARK, Calif. , May 7, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results from operations…
